Inspec

Inspec ROE

The Return on Equity (ROE) of Inspec (6656.T) as of Oct 21, 2026 is 7.41 %. In the previous year, Return on Equity (ROE) was -14.84 % — a change of -149.93% (higher).

ROE

7.41 %

YoY

-149.93%

Last updated:

In 2026, Inspec's return on equity (ROE) was 7.41 %, a -149.93% increase from the -14.84 % ROE in the previous year.

The Inspec ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2019
17.94 JPY
Jan 1, 2020
8.45 JPY
Jan 1, 2021
-132.26 JPY
Jan 1, 2022
14.29 JPY
Jan 1, 2023
5.60 JPY
Jan 1, 2024
-32.79 JPY
Jan 1, 2025
-14.84 JPY
Jan 1, 2026
7.41 JPY
The Inspec ROE history
YEARROEYoY
7.41 %-149.93%
-14.84 %-54.73%
-32.79 %-685.28%
5.60 %-60.79%
14.29 %-110.80%
-132.26 %-1,664.58%
8.45 %-52.89%
17.94 %-137.63%
-47.68 %-481.01%
12.52 %-416.27%
-3.96 %-125.45%
15.55 %+162.61%
5.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

ROE Details

Decoding Inspec's Return on Equity (ROE)

Inspec's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Inspec's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Inspec's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Inspec’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Inspec stock

Return on Equity (ROE) of Inspec is 7.41 % in 2026.

Return on Equity (ROE) of Inspec changed from -14.84 % to 7.41 %, representing a -149.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Inspec since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Inspec with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Inspec

All Key Metrics — Inspec